Panacos Pharmaceuticals Inc (Grey Market:PANC)

0.00
Delayed Data
As of Apr 15
 0.00 / 0.00%
Today’s Change
0.00
Today|||52-Week Range
0.01
-90.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$536.40

Company Description

Panacos Pharmaceuticals, Inc. is a development stage company engaged in the discovery and development of small-molecule oral drug which is designed to treat Human Immunodeficiency Virus and other major human viral diseases. Its primary product is Bevirimat which is an oral human immunodeficiency virus which provides a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in March 2005 and is headquartered in Watertown, MA.

Contact Information

Panacos Pharmaceuticals, Inc.
134 Coolidge Avenue
Watertown Massachusetts 02472
P:(617) 926-1551
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

John R. BarrPresident & Chief Executive Officer
Thomas T. HigginsChief Financial Officer

To view my watchlist

Not a member yet?

Sign up now for a free account